Your search returned 2 results.

Sort
Unhighlight Highlight
Select all Clear all
Select titles to:
Results
1.
Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31189519
Year: 2019
Citation:
  • The Lancet Diabetes & Endocrinology. 7(8):596-605, 2019 08.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Gonzalez-Galvez G, Gron R, Halladin N, Haluzik M, Jermendy G, Kok A, Orsy P, Sabbah M, Sesti G, Silver R
DOI:
Add to cart
2.
Advances in Diabetes Pharmacotherapy: An Update for the Emergency Provider. MedStar authors:
  • Mazer-Amirshahi, Maryann
PMID:
  • 28987311
Year: 2018
Citation:
  • Journal of Emergency Medicine. 54(1):73-80, 2018 Jan.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Emergency Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Mazer-Amirshahi M, Pourmand A
DOI:
Add to cart
Pages

Powered by Koha